Skip to content

Clinical study for integrated traditional Chinese and western medicine in preventing and treating premature ovarian insufficiency

Clinical study for integrated traditional Chinese and western medicine in preventing and treating premature ovarian insufficiency

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027742
Enrollment
Unknown
Registered
2019-11-24
Start date
2016-01-01
Completion date
Unknown
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary ovarian insufficient

Interventions

Sponsors

Jiangsu Province Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Women of reproductive age between 20 and 40 years old who meet the diagnostic criteria of POI; 2. No steroids within 3 months before enrollment; 3. With good compliance, agreed to enter this study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. POI caused by bilateral or unilateral ovariectomy. 2. Complicated with acute infectious diseases, cardiovascular diseases, renal diseases, liver diseases, hematopoietic diseases and other serious primary diseases. 3. Mental patients or those who cannot give full informed consent due to mental and behavioral disorders. 4. Allergic constitution or allergy to multiple drugs.

Design outcomes

Primary

MeasureTime frame
estradiol;Follicle-stimulating hormone;Luteinizing hormone;Inhibin B;anti-Mullerian hormone;Clinical pregnancy rate;

Secondary

MeasureTime frame
Kupperman modified scoring method;Ovarian volume;Ovarian blood flow;Ovarian reserve;

Countries

China

Contacts

Public ContactYong Tan

Department of Reproductive Medicine, Jiangsu Province Traditional Chinese Medicine Hospital

13951942495@163.com+86 13951942495

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026